药物对比
Insulin Regular Human vs Rosiglitazone
比较常规胰岛素与 rosiglitazone 治疗2型糖尿病。胰岛素为注射用短效制剂，rosiglitazone 为口服药，具有心血管与心力衰竭风险。
此页面暂无可用的对比维度。
临床背景
This comparison arises for type 2 diabetes patients considering thiazolidinedione therapy versus starting insulin.
结论
Insulin is more versatile and preferred for broader use while rosiglitazone has significant safety limitations.
全部药物对比